Knopp Biosciences LLC

États‑Unis d’Amérique


 
Quantité totale PI 26
Quantité totale incluant filiales 35 (+ 9 pour les filiales)
Rang # Quantité totale PI 56 706
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 476 061
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

12 2
0 0
12 0
0
 
Dernier brevet 2022 - Use of dexpramipexole for the tr...
Premier brevet 2007 - Compositions and methods of usin...
Dernière marque 2010 - KNOPP BIOSCIENCES
Première marque 2010 - KNOPP BIOSCIENCES

Filiales

1 subsidiaries with IP (9 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2021 Invention Use of dexpramipexole for the treatment of moderate to severe asthma. Disclosed herein are method...
2020 Invention Methods of use for kv7 channel activators. Provided herein are compounds and pharmaceutical compo...
Invention Compositions and methods of using (r)-pramipexole. Pharmaceutical compositions of (R)-pramipexol...
2019 Invention Kv7 channel activators compositions and methods of use. Provided herein are optionally substitute...
2018 Invention Imidazo[4,5-b]pyridin-2-yl amides as kv7 channel activators. Optionally substituted benzoimidazol...
Invention Compositions and methods for treating amyotrophic lateral sclerosis in responders. A method for t...
2017 Invention Benzoimidazol-1, 2-yl amides as kv7 channel activators. Optionally substituted benzoimidazol-1,2-...
2016 Invention Synthesis of chirally purified substituted benzothiazole diamines. Methods for preparing chirally...
Invention Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds. The present invention i...
2015 Invention Compositions and methods of using (r)-pramipexole. Pharmaceutical compositions of (R)-pramipexole...
Invention Compositions and methods of using r(+) pramipexole. Pharmaceutical compositions of R(+) pramipex...
Invention Benzoimidazol-1,2-yl amides as kv7 channel activators. Optionally substituted benzoimidazol-1,2-y...
2014 Invention Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders. ...
Invention Compositions and methods for treating chronic urticaria. Disclosed herein are methods of treating...
Invention Treating elevated levels of eosinophils and/or basophils. Disclosed herein are methods of treatin...
Invention Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators. Compounds represented by formula 1 ...
2013 Invention Synthesis of chirally purified substituted benzothiazole diamines. Methods for preparing chirall...
Invention Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and ...
Invention Compositions of r(+) and s(-) pramipexole and methods of using the same. Compositions of predete...
2012 Invention Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds. The present in...
Invention Compositions and methods for treating amyotrophic lateral sclerosis. Pharmaceutical compositions...
2011 Invention Compositions of r(+) and s(−) pramipexole and methods of using the same. Compositions of predeter...
Invention Compounds and methods of modulating mitochondrial bioenergetic efficiency through an interaction ...
2010 P/S Medical and scientific research services, namely, research and development, analysis, formulation...
2009 Invention Compositions and methods of using (r)- pramipexole. Pharmaceutical compositions of (R)-pramipexo...